1. Aed-efficacy and outcome measurements for effectiveness: evaluation of anti-epileptic drugs in the different phases of development.

   • D.G.A. Kasteleijn-Nolst Trenité
   • H. Meinardi
   • Y.A. Hekster

   Legacy Pages: 213 - 213

2. Better comparisons of antiepileptic drugs: what measures of efficacy?

   • David Chadwick

   OriginalPaper Pages: 214 - 216

3. Evaluation of drug treatment outcome in epilepsy: a clinical perspectiv

   • Emilio Perucca

   OriginalPaper Pages: 217 - 222

4. Evaluation of drug treatment outcome in epilepsy: a clinical perspectiv

   • Fred Schobben
   • Yechiel Hekster
   • Barbara van Zwieten‐Boot

   OriginalPaper Pages: 223 - 226

5. Quality of Life as an Outcome Measure for Epilepsy Clinical Trials.

   • Joyce A. Cramer

   OriginalPaper Pages: 227 - 230

6. Discussion of the AED workshop.

   • D.G.A. Kasteleijn-Nolst Trenité
   • J.W.A. Meijer

   OriginalPaper Pages: 231 - 235

7. Discussion of the AED workshop.

   • Santiago Grau
   • Josep Monterde
   • Margarita Salvadó

   Legacy Pages: 236 - 245

8. Discussion of the AED workshop.

   • Zafar Iqbal
   • J.M. Midgley
   • W. Wilson

   OriginalPaper Pages: 246 - 250

9. Calcium dobesilate-induced agranulocytosis.

   • Elena García Benayas
   • Benito García Díaz
   • Guillermo Pérez

   OriginalPaper Pages: 251 - 252

10. Apoptosis: molecular mechanisms and implications for cancer chemotherapy

    • H.J. Gugelaar
    • A. Vermes
    • C. Haanen

    Erratum Pages: 253 - 253